Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors - Wikidata - wikimedia - TriplyDB

Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors

Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors

http://www.wikidata.org/entity/Q33864448

about

Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1 Keystone symposium: the role of microenvironment in tumor induction and progression, Banff, Canada, 5-10 February 2005 Molecular underpinnings of corneal angiogenesis: advances over the past decade Capillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signaling Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities Matrix metalloproteinases and the regulation of tissue remodelling An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis Lack of collagen XVIII/endostatin exacerbates immune-mediated glomerulonephritis.Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer Targeting the tumor microenvironment.Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth.NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement.Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo.DNA methylation profile distinguishes clear cell sarcoma of the kidney from other pediatric renal tumors Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness.Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner.Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch.Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular Matrix Tumor stroma derived biomarkers in cancer.Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition.Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1).The clinical potential of antiangiogenic fragments of extracellular matrix proteins Structural basis for the functions of endogenous angiogenesis inhibitors.Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers CD47-retargeted oncolytic adenovirus armed with melanoma differentiation-associated gene-7/interleukin-24 suppresses in vivo leukemia cell growth Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1.A phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanoma.Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer Acrolein: unwanted side product or contribution to antiangiogenic properties of metronomic cyclophosphamide therapy?Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.Constitutive expression of IL-12R beta 2 on human multiple myeloma cells delineates a novel therapeutic target.Signaling mechanisms of endogenous angiogenesis inhibitors derived from type IV collagen.Novel aspects of corneal angiogenic and lymphangiogenic privilege.Vector-mediated Tum-5 expression in neovascular endothelial cells for treating hepatocellular carcinoma.Antiangiogenic anticancer strategy based on nanoparticulate systems.COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets.Vascular endothelial growth factor trap-eye and trap technology: Aflibercept from bench to bedside.EG-VEGF, BV8, and their receptor expression in human bronchi and their modification in cystic fibrosis: Impact of CFTR mutation (delF508).Degraded iota-carrageenan can induce apoptosis in human osteosarcoma cells via the Wnt/β-catenin signaling pathway.

P2860

Q24298191-F32F4F7A-10F7-43ED-8A2B-88F68DB6AE86 Q24810275-29ED28F4-DC2D-476F-B7EC-027202C562A7 Q26747539-B29C1621-04B5-47A8-87B0-A38BD65CCF56 Q28581719-55DC1D64-8051-48A4-8068-CCA648DD1F24 Q28751757-656253BC-611F-4258-89BF-4A3F49CD2FD3 Q29618747-7CA1F831-670D-4536-90D9-1910220737C5 Q30480495-3BD766CF-D4BA-4EE8-9C13-CCC2A12B9BDE Q30497785-968D8C73-78F3-4D80-AF66-E3797DCA981F Q33398689-FC5495A7-623A-4B54-8D00-92BD1997119C Q33736691-5722FEB1-635A-436A-A4C7-2E302DDE4FCE Q33789026-2CCB4AA0-ADB6-47FB-9460-2348A6878892 Q34033879-3CAF7FF3-FDF1-4C25-B556-5015764062EE Q34044998-6690E9FD-1683-43A9-B361-5F075695B28E Q34701105-EB3294C6-5B66-43DA-A30A-9A3AE3265D16 Q35010424-05C8F40B-352A-4094-A661-BBFB12BBAD2F Q35049228-B1A4ED8F-2341-4A97-AAA8-4B81CB7D4A11 Q35133764-A9772D6E-FBBF-4DA4-AE97-F7D1B1360563 Q35662667-0F8E3C73-D2BE-461F-8F7A-17D713F37AD9 Q35679807-D3F53E71-AA73-42A4-BC60-7F89406378C1 Q35765454-204817AE-CAC6-4EA4-9EEE-0D5A3D578C92 Q36094099-D492F177-51EC-45FE-BEAA-AC036E7EE949 Q36140753-F7A07BB2-0ACB-4D4A-8775-A95D3F88E064 Q36290509-300A41AB-F455-49A0-B572-388197FA56F6 Q36547755-6A29BD9F-375E-49B0-A4D2-D3990ED4ABD8 Q36578668-AD3FA300-FC44-43B7-B697-B42E02AB30E3 Q36685435-86053E17-5E65-43B8-BF22-746E458F2E75 Q36902175-29685AB2-A8E8-4852-90ED-61765F78477F Q36984477-AEFF3006-B8F6-4B50-9E51-B629747BA9B9 Q37269683-DA1A4D16-58FF-448C-A8E2-3FB4BF05CE02 Q37310699-6A54A4A4-38CF-4548-BD87-48D1BB9A958F Q37346912-538C6CED-383B-47B0-808F-A15FFA4A682A Q37351173-4F853F6E-63FD-4279-84C5-92F5F195A4A8 Q37380604-4C058D02-FE31-4955-97AD-C64342E4CC60 Q37681157-E28D1518-A6B5-4C17-94B6-E022521BD4EF Q37734962-E2D901A6-6834-469F-93B3-C35E06A18C75 Q37876400-C0AC57E1-CDA8-4903-88A8-E82542CA05CB Q38036904-988C7333-D406-49EA-B3F8-CFA19F325E96 Q38266022-90C9EC15-3D10-4320-984E-7A4AD2835DBF Q38866990-026E187D-A8B9-4E58-A5CD-41FA7472787B Q39201605-9DF508AA-9CA7-45C5-B8DA-FD22E9875E3A

P2860

Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors

http://www.wikidata.org/entity/Q33864448

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Function of endogenous inhibit ...... ium-specific tumor suppressors

@ast

Function of endogenous inhibit ...... ium-specific tumor suppressors

@en

type

label

Function of endogenous inhibit ...... ium-specific tumor suppressors

@ast

Function of endogenous inhibit ...... ium-specific tumor suppressors

@en

prefLabel

Function of endogenous inhibit ...... ium-specific tumor suppressors

@ast

Function of endogenous inhibit ...... ium-specific tumor suppressors

@en

P1433

Q33864448-32C8DCF7-1DBE-4145-8792-B1B29266082E

P1476

Q33864448-C62E3BFC-5843-4394-97F2-B611AB8ED572

P2093

Q33864448-0BDB5F78-BAE9-47F0-BC23-7A6ACCC97147

Q33864448-2C38A326-4601-438B-9F4C-DC2E2AB58DBC

Q33864448-38128104-F9D7-4C4B-9E86-72B2B534784F

Q33864448-3E337228-9FAB-4ED5-B34D-82C6BFA9B475

Q33864448-47ACF706-F59C-4BE3-959D-5DDC033A46AF

Q33864448-66619BCE-F41A-4B41-A88D-038064CA8038

Q33864448-6E9BD175-BE3C-435F-A98F-0FC9E11344C0

Q33864448-E3EA3A96-0B8F-41C0-B99A-108438B8A898

P2860

Q33864448-03BFB4F5-8459-427F-BA07-B2F105E0275A

Q33864448-09113FE2-4C3B-45B2-A54B-8FA82C1B926F

Q33864448-0B652310-E91E-4F80-9ABD-CBBA9E8EE9E0

Q33864448-0DBFFCF0-0CC6-4883-949A-00BEF3BC2340

Q33864448-1F138A13-DDBE-4FCB-AA76-298BB280415E

Q33864448-2B4EE7DB-7BC5-48FD-B987-894CA02AC09A

Q33864448-30000A1F-52EF-4C7D-9395-2E7049B9AE31

Q33864448-3231110C-4A02-4B99-8AF0-5B8F5E4357F3

Q33864448-395B8BB5-59F4-4482-B041-8F06ECC46FC0

Q33864448-4598553B-D773-48B5-9A83-17981D2EA139

P304

Q33864448-EB9962D0-13AA-4CFC-A4EC-86D984675BB4

P31

Q33864448-BE638FB4-4B9A-4216-B2EE-80EE7DD8CCB3

P356

Q33864448-BC38B293-6C76-441E-B7AD-9C8E07C63687

P407

Q33864448-48D33D67-886E-4273-AED8-69E59D769F8C

P433

Q33864448-0F977BFF-A9EA-4818-A6F0-48EFF1A933B5

P478

Q33864448-57FCF797-4898-4DD1-9037-2D42A4B5B70E

P50

Q33864448-2E4A23DB-7597-49DA-9B10-0088E5ADBE53

Q33864448-74012A1F-86B3-4216-A7F7-FE69592D6AB6

Q33864448-EDA1BE91-DB03-4892-B24A-7A85AD6CF5DF

P577

Q33864448-84C437D1-5483-43A7-8750-42F5B30DEBD9

P5875

Q33864448-C2FA80F8-E47F-471E-9CD3-14484FC9FAB0

P698

Q33864448-6936E993-69C0-45E6-848E-D4E2EA8898FD

P921

Q33864448-359EC750-AA0B-4A0E-8851-2FE0E857D0A8

P932

Q33864448-975D18DC-4D76-4614-8271-5D5402F4A3DA

P356

PNAS.0500180102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Function of endogenous inhibit ...... ium-specific tumor suppressors

@en

P2093

Akulapalli Sudhakar

http://www.w3.org/2001/XMLSchema#string

Amish Shah

http://www.w3.org/2001/XMLSchema#string

Hikaru Sugimoto

http://www.w3.org/2001/XMLSchema#string

Jack Lawler

http://www.w3.org/2001/XMLSchema#string

Laura E Benjamin

http://www.w3.org/2001/XMLSchema#string

Mary Soubasakos

http://www.w3.org/2001/XMLSchema#string

Udaya Yerramalla

http://www.w3.org/2001/XMLSchema#string

Yuki Hamano

http://www.w3.org/2001/XMLSchema#string

P2860

Distinct antitumor properties of a type IV collagen domain derived from basement membrane

Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism.

Interaction of endostatin with integrins implicated in angiogenesis

Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin

Angiogenesis in cancer and other diseases

Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats

Lack of collagen XVIII/endostatin results in eye abnormalities

Angiogenesis in cancer, vascular, rheumatoid and other disease

P304

2934-2939

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0500180102

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8022093

http://www.w3.org/2001/XMLSchema#string

P698

15710885

http://www.w3.org/2001/XMLSchema#string

P921

P932

549486

http://www.w3.org/2001/XMLSchema#string